First Trust Advisors’s Rhythm Pharmaceuticals RYTM Stock Holding History
Bought
Maintained
Sold
Other funds holding RYTM
BBA
First Trust Advisors's RYTM Position: Q3 2026 in Review
First Trust Advisors increased its Rhythm Pharmaceuticals (RYTM) stake by 124% in Q3 2026, buying an estimated $4.31M and bringing the position to 72,899 shares worth $6.94M. The position accounts for ﹤0.01% of the portfolio, ranked #1378.
First Trust Advisors first reported a position in RYTM in Q2 2023 and has held it in 12 quarters since. The position peaked at $9.47M in Q4 2025. 333 funds tracked by Wall St. Rank hold RYTM as of Q3 2026.
- First Trust Advisors held 72,899 shares of Rhythm Pharmaceuticals worth $6.94M as of Q3 2026.
- First Trust Advisors bought 40,417 Rhythm Pharmaceuticals shares in Q3 2026, an estimated $4.31M.
- Rhythm Pharmaceuticals made up ﹤0.01% of First Trust Advisors's portfolio in Q3 2026, its #1378 holding.
- First Trust Advisors first reported a position in Rhythm Pharmaceuticals in Q2 2023 and has held it in 12 quarters since.
- First Trust Advisors's Rhythm Pharmaceuticals position peaked at $9.47M in Q4 2025.
- 333 funds tracked by Wall St. Rank held Rhythm Pharmaceuticals as of Q3 2026.
Based on First Trust Advisors's 13F filing for Q3 2026, filed 12 Nov 2026.